Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Co-treatment With Recombinant Growth Hormone (GH) in Poor Responders Treated by in Vitro Fertilization (IVF-ET)

NCT01204840 is registered in ClinicalTrials.gov with Ottawa Fertility Centre as lead sponsor.

NCT NCT01204840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01204840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Co-treatment With Recombinant Growth Hormone (GH) in Poor Responders Treated by in Vitro Fertilization (IVF-ET)
Lead sponsor
Ottawa Fertility Centre
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
May 31, 2015
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, poor ovarian reserve